UHLMANN PRICE SECURITIES’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Sell
4,508
-193
-4% -$197K 0.2% 11
2026
Q1
$4.25M Buy
+4,701
New +$4.77M 0.29% 12
2025
Q2
– Sell
-378
Closed -$312K – 198
2025
Q1
$312K Hold
378
– – 0.23% 107
2024
Q4
$292K Hold
378
– – 0.22% 111
2024
Q3
$335K Buy
+378
New +$340K 0.27% 104

Other funds holding LLY

UHLMANN PRICE SECURITIES's LLY Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES reduced its Eli Lilly (LLY) stake by 4.1% in Q2 2026, selling an estimated $197K and leaving 4,508 shares worth $5.41M. The position accounts for 0.2% of the portfolio, ranked #11.

UHLMANN PRICE SECURITIES first reported a position in LLY in Q3 2024 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • UHLMANN PRICE SECURITIES held 4,508 shares of Eli Lilly worth $5.41M as of Q2 2026.
  • UHLMANN PRICE SECURITIES sold 193 Eli Lilly shares in Q2 2026, an estimated $197K.
  • Eli Lilly made up 0.2% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #11 holding.
  • UHLMANN PRICE SECURITIES first reported a position in Eli Lilly in Q3 2024 and has held it in 5 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.